Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization

American Journal of Clinical Pathology

Volumn 129, Issue 5, 2008, Pages 749-755

  LeGallo, Robin D ^a   Stelow, Edward B ^a   Ramirez, Nilsa C ^b   Atkins, Kristen A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

FISH; Fluorescent in situ hybridization; Gynecology; HER2; Hydatidiform mole; p57

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PARAFFIN; PROTEIN P57; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ABORTION; ARTICLE; CONSENSUS; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; PRIORITY JOURNAL; STAINING; TRIPLOIDY; BIOSYNTHESIS; COMPARATIVE STUDY; METABOLISM; PLOIDY; PREGNANCY; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PLOIDIES; PREGNANCY; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 44849131092     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7XRL378C22W7APBT     Document Type: Article

References (21)

1. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335:1740-1748.
2. Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000;356:36-39.
3. Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176-187.
4. Soper JT, Mutch DG, Schink JC, American College of Obstetricians and Gynecologists. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol. 2004;93:575-585.
5. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted CDK inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269-276.
6. Merchant SH, Amin MB, Viswanatha DS, et al. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol. 2005;36:180-186.
7. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25:1225-1230.
8. Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol. 2002;33:1188-1192.
9. Fukunaga M. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med. 2004;128:897-900.
10. Sebire NJ, Lindsay I. p57KIP2 immunostaining in the diagnosis of complete versus partial hydatidiform moles [letter]. Histopathology. 2006;48:873-874.
11. Fukunaga M, Katabuchi H, Nagasaka T, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29:942-947.
12. Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007;71:25-34.
13. Van den Veyver IB, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update. 2006;12:233-242.
14. Petersen BL, Sorensen MC, Pedersen S, et al. Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method. Appl Immunohistochem Mol Morphol. 2004;12:259-265.
15. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002;161:1961-1971.
16. Nagaishi M, Yamamoto T, Iinuma K, et al. Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan. J Obstet Gynaecol Res. 2004;30:237-241.
17. Philipp T, Philipp K, Reiner A, et al. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod. 2003;18:1724-1732.
18. Yazaki-Sun S, Daher S, de Souza Ishigai MM, et al. Correlation of c-erbB-2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole. J Obstet Gynaecol Res. 2006;32:265-272.
19. Genest DR, Ruiz RE, Weremowicz S, et al. Do nontriploid partial hydatidiform moles exist? a histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med. 2002;47:363-368.
20. Murdoch S, Djuric U, Mazhar B, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38:300-302.
21. Fisher RA, Hodges MD, Rees HC, et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet. 2002;11:3267-3272.